Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03388827
Other study ID # ZUH- 9
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date December 20, 2017
Est. completion date January 2019

Study information

Verified date December 2017
Source Zagazig University
Contact ibrahim A EL sharkwy
Phone 00966554818576
Email ibrahimsharkwy@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Laminaria and Misoprostol before Operative Hysteroscopy


Description:

The use of laminaria versus laminaria plus misoprostol was compared before operative hysteroscopy in nulliparous women to assess the efficacy of both methods in cervical dilatation.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date January 2019
Est. primary completion date December 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: nullipara

- need hystroscopic intervention

Exclusion Criteria: previous pregnancy

cervical lesion

contraindication to misoprostol

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Laminaria tent
Laminaria tent was inserted for 12 hours before Hysteroscopy
Drug:
Laminaria plus Misoprostol
Laminaria plus Misoprostol were inserted for 12 hours before Hysteroscopy

Locations

Country Name City State
Egypt Zagazig University Zagazig ,

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Preoperative cervical width cervical width in Hegar dilators number 12 hours
Secondary adverse effects adverse effects of the method used or hysteroscopy 24 hours
See also
  Status Clinical Trial Phase
Completed NCT02986880 - Effect of Type-A Botulinum Toxin in the Post-radiosurgical Neck Contractures Phase 2